Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 277 - 288 items out of 316 results
ILCN article
First-line Nivolumab + Ipilimumab Superior to Chemotherapy in Metastatic NSCLC at 6 Years
ILCN article
Study Shows Exhaled Breath May Track Treatment Response in Mesothelioma
ILCN article
IASLC’s New 5-Year Strategic Plan Unveiled at Business Meeting
ILCN article
Modified Lung Cancer Screening Eligibility Requirements May Reduce Racial Disparities in Lung Cancer Screening, Treatment
ILCN article
Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data
ILCN article
Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question
ILCN article
Experts Debate Addition of Frontline Chemotherapy for EGFR+ NSCLC
ILCN article
Should Biomarkers Be Used in the Clinical Management of ES-SCLC?
ILCN article
FLAURA 2 Post-progression Outcomes Demonstrate Consistent Benefit, Favor Combination Arm
ILCN article
MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination
ILCN article
Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm?
ILCN article
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Pagination
First
First page
‹
Previous page
…
19
20
21
22
23
24
25
26
27
›
Next page
Last
Last page